Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 468117011000036114 | Plasma-Lyte 148 Replacement (magnesium chloride 300 mg / 1 L + potassium chloride 370 mg / 1 L + sodium acetate trihydrate 3.68 g / 1 L + sodium chloride 5.26 g / 1 L + sodium gluconate 5.02 g / 1 L) intravenous infusion injection, 1 x 1 L bag (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 468118011000036110 | Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | Is a | trade product pack | false | Inferred relationship | Some | ||
| Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | Is a | sodium gluconate 5.02 g/L + sodium chloride 5.26 g/L + potassium chloride 370 mg (potassium 5 mmol)/L + magnesium chloride 300 mg (magnesium 1.5 mmol)/L + sodium acetate trihydrate 3.68 g/L injection, 1 L bag | false | Inferred relationship | Some | ||
| Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | has TPUU | Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | false | Inferred relationship | Some | ||
| Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | has TP | Plasma-Lyte 148 Replacement | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | Is a | False | Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set
FHIR